HUEMOELLER JOHN WALTER II 4/A
4/A · AXIM BIOTECHNOLOGIES, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4/AAmended
HUEMOELLER JOHN WALTER II
Director
Transactions
- Award
Convertible Note
2024-03-15$250000.00/sh+250,000$62,500,000,000→ 30,000,000 totalExercise: $0.01From: 2026-01-23Exp: 2033-01-24→ Common Stock (25,000,000 underlying) - Award
Convertible Note
2024-03-15$250000.00/sh+250,000$62,500,000,000→ 42,500,000 totalExercise: $0.02From: 2024-03-15Exp: 2034-03-01→ Common Stock (12,500,000 underlying)
Footnotes (2)
- [F1]Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share.
- [F2]Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share.